Patients whose immune systems are weakened due to cancer, organ or bone marrow transplants, chronic diseases, or the medications used to treat these conditions may feel like they have enough on their plates without worrying about whether and when they should take an additional dose of COVID-19 vaccine and a flu shot.
Researchers at Moffitt Cancer Center are working to develop a dendritic cell vaccine targeting HER3, a protein involved in the growth and spread of many different cancer types. Their pre-clinical work has been published in the journal Cancer Immunology Research.
Kizzmekia S. Corbett, well known for her work on the mRNA vaccines used to protect against Covid-19, has been named the recipient of the 2021 E.E. Just Award by the ASCB.
Vaccine hesitancy is considered one of the top 10 threats to public health by the World Health Organization.
Dec. 1, 2021— People living with HIV experience more severe outcomes and have higher comorbidities from COVID-19 than people not living with HIV, according to the 2020 UNAIDS Global Update. In mid-2021, most people living with HIV did not have access to COVID-19 vaccines. This World AIDS Day, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is calling on governments, health advocates and non-government organisations to strengthen their response to AIDS and COVID-19 by making COVID-19 vaccines more accessible worldwide.
UC San Diego nanoengineers developed a new and potentially more effective way to deliver messenger RNA (mRNA) into cells. Their approach involves packing mRNA inside nanoparticles that mimic the flu virus—a naturally efficient vehicle for delivering genetic material such as RNA inside cells.
Kaiser Permanente research in Southern California published Nov. 25, 2021, in The Lancet Regional Health – Americas confirmed high Moderna COVID-19 vaccine effectiveness up to 5 months after the second dose.
Rutgers, a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children, is looking for participants for a third clinical trial on children ages 6 months to 4 years.
A new article published in The New England Journal of Medicine suggests that secondary antibodies known as “anti-idiotype antibodies” could be responsible for some of the side effects of COVID-19 vaccines and the symptoms of long-haul COVID.
Individuals with kidney failure who were on dialysis had an incomplete and delayed antibody response and a blunted cellular immune response following COVID-19 vaccination, compared with people with normal kidney function.
A vaccine booster is readied for use.
A new study summarized in a research letter to be published in JAMA Pediatrics reveals that a number of factors, including negative impacts from the pandemic during pregnancy and reports of discrimination, made it less likely that infants received their recommended vaccinations in the first months of their lives.
While cases appear to have fallen in Uttar Pradesh as well as most locations in India, it’s not clear why. Many other factors, including immunity from a previous infection, vaccination, and lockdowns, likely helped reduce the number of cases.
The Institute for Molecular Medicine will advance the manufacturing of Duvax for the first clinical trials of a dual vaccine for Alzheimer's disease to begin in 2023
Cedars-Sinai physicians who have been on the front lines in the battle against COVID-19 in the community are also doing their part at home by getting their children vaccinated against the virus.
People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer's COVID-19 vaccine, according to a study from Washington University School of Medicine in St. Louis. A third vaccine dose drove antibody levels back up, indicating that this additional dose may provide protection as the virus's delta variant continues to spread.
As widely-anticipated decisions about COVID-19 vaccine boosters roll out from U.S. agencies today, insights from an independent study underscore why boosters are important for all adults.
A virtual workshop for users of the Advanced Photon Source and the Center for Nanoscale Materials highlighted pioneering research to understand the SARS-CoV-2 virus and its variants that cause COVID-19.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) conducted a head-to-head test of the second-generation vaccine CV2CoV compared with CVnCoV. The scientists assessed the vaccines’ ability to provoke an immune response as well as their protective efficacy against COVID-19 in non-human primates.
Loyola Medicine is now offering the COVID-19 vaccine to children ages 5 to 11 at multiple clinic sites, including mobile vaccine clinics. The Pfizer COVID-19 vaccine was authorized for emergency use for children ages 5 to 11. It is a two-dose series taken three weeks apart. Each dose will be 1/3 the dosage of the adolescent/adult vaccine.
A randomized controlled trial of 2,275 women in Kenya showed that a single dose of the HPV vaccine was highly effective. The current standard for women is three doses. This news could greatly hasten the pace of vaccinations and brings renewed energy to make cervical cancer the first cancer to be wiped out.
Research by UCLA Fielding School's UCLA Center for Health Policy Research, led by Dr. Ninez Ponce, Fielding School professor of health policy and management, found that Californians have varied their COVID-19 risk reduction based on their test results
The CDC’s vaccine prioritization strategy performed well compared to other approaches, though with some room for improvement
Iowa State University researchers were part of a team evaluating possible strategies the CDC could have recommended last winter for COVID-19 vaccine rollouts.
Wealthier nations should pay a COVID-19 vaccine tax as part of the price they pay to manufacturers, to ensure a fairer distribution of the jab to poorer nations, argues a political scientist in the Journal of Medical Ethics.
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced its plenary speakers for Virtual ISPOR Europe 2021 scheduled for 30 November - 3 December.
A survey of parents and caregivers of children with cancer found that nearly a third of them expressed hesitancy to vaccinate their youngsters against COVID-19.
Close to 10 million children in lower-income countries have never been vaccinated against any infectious disease. These “zero-dose” kids hold a lesson for all of us, says Canadian public-health expert Mira Johri.
New research from McMaster University, aimed at understanding the immune response to COVID-19 vaccines, found some long-term care residents no longer had high antibody levels months after their second dose, directly supporting government decisions to provide third doses.
A recent study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes produced by people who received either of the two available messenger RNA (mRNA) vaccines for COVID-19 persist six months after vaccination at only slightly reduced levels from two weeks after vaccination.
Most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 were helped by a third vaccine dose, according to a new study by investigators at the Montefiore Einstein Cancer Center (MECC). The findings, published online today in Cancer Cell, also show that a “booster” shot is extremely beneficial for all cancer patients, who face a heightened risk of severe disease and dying from COVID-19, and particularly in people who have a blood cancer.
If you got the COVID-19 shots back in early spring, your antibodies are likely waning. But it’s not something you need to be worried about, according to a new study from the University of Georgia.
With the holiday season here, and COVID-19 vaccines rolling out to millions of American children 5-11 years old, celebrations could look a little different this year compared to the scaled back or cancelled holiday plans in 2020. While experts say small gatherings for those who are vaccinated can be safe for the holidays this year, a new national survey conducted by The Ohio State University Wexner Medical Center found many Americans still plan to celebrate very cautiously.
Austria will impose a nationwide lockdown for people who have not been vaccinated against COVID-19. Will it be the first country in the world to do so? Not entirely.
For the second straight year, flu season is emerging against the backdrop of the COVID-19 pandemic. While the number of flu cases was relatively low last year, experts at Johns Hopkins Medicine say that this year, it could be much higher.
A Q&A with a University of Florida Health allergist and immunologist
在家人齐聚共度节假日之际，免疫力低下的患者务必采取额外的措施，保护自己免于罹患COVID-19（2019 冠状病毒病），这一点很重要。免疫系统受损的人患上COVID-19重症的风险更高。这些人包括癌症患者、接受了移植手术并正在服用免疫抑制药物的患者，以及感染艾滋病毒/艾滋病的晚期和未接受过治疗的患者。
مدينة روتشستر، ولاية مينيسوتا- بينما تتجمع العائلات لقضاء العطلات، من المهم للمرضى الذين يعانون من نقص المناعة اتخاذ خطوات إضافية للمساعدة في حماية أنفسهم من فيروس كورونا المستجد (كوفيد-19). الأشخاص المصابون بضعف في جهاز المناعة عرضة بشكل أكبر لخطر المرض الشديد جرَّاء فيروس كورونا المستجد (كوفيد-19
Conforme as famílias se reúnem para as festas de final de ano, é importante que os pacientes imunocomprometidos tomem medidas extras para ajudar a se proteger da COVID-19. Pessoas com o sistema imunológico enfraquecido correm maior risco de adoecer gravemente com a COVID-19.
Dada la proximidad de las reuniones familiares para celebrar las festividades, es importante que los pacientes con compromiso inmunitario tomen medidas adicionales para protegerse contra la COVID-19.
With conversations about COVID-19 vaccinations a likely centerpiece this holiday season, resources from the American Association of Critical-Care Nurses can help individuals prepare for potentially challenging discussions with family and friends who are hesitant about the vaccine.
Houston Methodist’s SARS-CoV-2 genome sequencing team has partnered on a study led by Penn State that revealed 80% of white-tailed deer sampled across Iowa at the height of the 2020-2021 deer-hunting season tested positive for the SARS-CoV-2 virus. Analysis of the virus genome sequences revealed infections were likely the result of multiple human-to-deer transmission “spillover” events followed by deer-to-deer transmission from April 2020 through January 2021.
People with blood cancers are at a higher risk than healthy individuals for severe and life-threatening COVID-19 illness; furthermore, research suggests that they do not always achieve optimal protection from vaccination.
As families prepare to gather later this month for Thanksgiving, it is important for patients who are immunocompromised to take extra steps to protect themselves from becoming infected with COVID-19. People who are immunocompromised have weakened immune systems, which means they have a higher risk of becoming severely ill from COVID-19.
The new drug candidate, Paxlovid, significantly reduced hospitalization and death in adult patients, according to Pfizer, and will be submitted for an emergency use authorization in the United States. Data was taken at IMCA-CAT at the APS.
Université de Montréal chemists looked at lab samples of patients who recovered from a mild case of COVID-19 and found that those over 50 produced more antibodies against the SARS-CoV-2 virus.
Currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
